Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ruprecht

Showing results (161-170 of 207) with videos related to

Pageof 21
Sort By:
Infection and Immunity|February 7, 2007
Coinfection with Schistosoma mansoni reactivates viremia in rhesus macaques with chronic simian-human immunodeficiency virus clade C infectionMila Ayash-Rashkovsky, Agnès-Laurence Chenine, Lisa N Steele, et al.
Retrovirology|October 22, 2008
SHIV-1157i and passaged progeny viruses encoding R5 HIV-1 clade C env cause AIDS in rhesus monkeysMichael Humbert, Robert A Rasmussen, Ruijiang Song, et al.
Journal of Human Virology|July 5, 2001
Potent neutralization of primary human immunodeficiency virus clade C isolates with a synergistic combination of human monoclonal antibodies raised against clade BW Xu, B A Smith-Franklin, P L Li, et al.
Plos One|April 13, 2011
R5-SHIV induces multiple defects in T cell function during early infection of rhesus macaques including accumulation of T reg cells in lymph nodesMichael Santosuosso, Elda Righi, E David Hill, et al.
Journal of Virology|May 16, 2008
Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity against self-antigensMei-Yun Zhang, Bang K Vu, Anil Choudhary, et al.
Plos One|July 30, 2011
Vaccination against heterologous R5 clade C SHIV: prevention of infection and correlates of protectionSamir K Lakhashe, Wendy Wang, Nagadenahalli B Siddappa, et al.
Virology|March 28, 2008
Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccinationVictoria R Polonis, Bruce K Brown, Andrew Rosa Borges, et al.
Plos One|June 28, 2012
Isolation of monoclonal antibodies with predetermined conformational epitope specificityAnton M Sholukh, Muhammad M Mukhtar, Michael Humbert, et al.
Plos One|July 27, 2010
R5 clade C SHIV strains with tier 1 or 2 neutralization sensitivity: tools to dissect env evolution and to develop AIDS vaccines in primate modelsNagadenahalli B Siddappa, Jennifer D Watkins, Klemens J Wassermann, et al.
Virology|March 27, 2013
Impact of antibody quality and anamnestic response on viremia control post-challenge in a combined Tat/Env vaccine regimen in rhesus macaquesThorsten Demberg, Egidio Brocca-Cofano, Seraphin Kuate, et al.
Pageof 21

Showing results (161-170 of 207) with videos related to

Sort By:
Pageof 21
Infection and Immunity|February 7, 2007
Coinfection with Schistosoma mansoni reactivates viremia in rhesus macaques with chronic simian-human immunodeficiency virus clade C infectionMila Ayash-Rashkovsky, Agnès-Laurence Chenine, Lisa N Steele, et al.
Retrovirology|October 22, 2008
SHIV-1157i and passaged progeny viruses encoding R5 HIV-1 clade C env cause AIDS in rhesus monkeysMichael Humbert, Robert A Rasmussen, Ruijiang Song, et al.
Journal of Human Virology|July 5, 2001
Potent neutralization of primary human immunodeficiency virus clade C isolates with a synergistic combination of human monoclonal antibodies raised against clade BW Xu, B A Smith-Franklin, P L Li, et al.
Plos One|April 13, 2011
R5-SHIV induces multiple defects in T cell function during early infection of rhesus macaques including accumulation of T reg cells in lymph nodesMichael Santosuosso, Elda Righi, E David Hill, et al.
Journal of Virology|May 16, 2008
Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity against self-antigensMei-Yun Zhang, Bang K Vu, Anil Choudhary, et al.
Plos One|July 30, 2011
Vaccination against heterologous R5 clade C SHIV: prevention of infection and correlates of protectionSamir K Lakhashe, Wendy Wang, Nagadenahalli B Siddappa, et al.
Virology|March 28, 2008
Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccinationVictoria R Polonis, Bruce K Brown, Andrew Rosa Borges, et al.
Plos One|June 28, 2012
Isolation of monoclonal antibodies with predetermined conformational epitope specificityAnton M Sholukh, Muhammad M Mukhtar, Michael Humbert, et al.
Plos One|July 27, 2010
R5 clade C SHIV strains with tier 1 or 2 neutralization sensitivity: tools to dissect env evolution and to develop AIDS vaccines in primate modelsNagadenahalli B Siddappa, Jennifer D Watkins, Klemens J Wassermann, et al.
Virology|March 27, 2013
Impact of antibody quality and anamnestic response on viremia control post-challenge in a combined Tat/Env vaccine regimen in rhesus macaquesThorsten Demberg, Egidio Brocca-Cofano, Seraphin Kuate, et al.
Pageof 21